Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?

Three-day artemisinin-based combination therapy (ACT) is the current standard of care for the treatment of malaria. However, specific drug resistance associated with reduced efficacy of ACT has been observed, therefore necessitating the clinical development of new anti-malarial drugs and drug combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbassi, Dorothea Ekoka, Pfaffendorf, Christoph, Mombo-Ngoma, Ghyslain, Kreuels, Benno, Ramharter, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280843/
https://www.ncbi.nlm.nih.gov/pubmed/37340324
http://dx.doi.org/10.1186/s12936-023-04606-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280843/
https://www.ncbi.nlm.nih.gov/pubmed/37340324
http://dx.doi.org/10.1186/s12936-023-04606-2

Ejemplares similares